Journalist Hunt

Resources ▾

Journalist DatabaseFor JournalistsPricing
LoginSign up

Dora Guerra - Journalist Profile | Connect with top journalists

View 's journalist industries, journalist types, location, and media outlets. Use Journalist Hunt to get connected with top journalists in seconds.

Get connected with journalists today
Music and Pop Culture Reporter, G1

Dora Guerra

Verified

Music and Pop Culture Reporter, G1

Belo Horizonte

Beats

Primary beats

EntertainmentArts

Secondary beats

InterviewsMusicTrendingPlantsBikingVideo GamesSailingPop CultureWineArt BusinessApparelExpedition CruisingTheaterVancouver TheatreNon-Profits

Biography

Final Covers

Cronaca Cultura.

Doesn’t Cover

I do not cover any subject which the majority of people would find boring.

Journalist Type

Reporter

Seniority Positions

Reporter

Industries

Online Media

Medium Formats

Entertainment Media

Content

Total articles 347

  • Available on paid plans

    Funkeiro lançou mais de 3 mil músicas em um ano com estratégia incomum; entenda

    By Dora Guerra Verified

    Apr. 16, 2025

  • Available on paid plans

    g1 Ouviu #305 - Sepultura: quarenta anos de altos e baixos e a turnê derradeira

    By Dora Guerra Verified, Juliene Moretti Verified

    Apr. 01, 2025

  • Available on paid plans

    Descanso ou desinteresse? Lollapalooza teve público sentado e até de costas para shows menores

    By Dora Guerra Verified

    Apr. 01, 2025

As seen in

Tribuna Online,Queijo Quente,Tnonline,MSN Brasil,Estadão,Isso É Fantástico,Estadao E+,Terra,G1,Jornal A Crítica

Company Info

G1

G1 Therapeutics, Inc. is a biopharmaceutical company based in Research Triangle Park, North Carolina. Founded in 2008, it focuses on developing small molecule therapies for cancer treatment. The company aims to improve patient outcomes by targeting cellular pathways involved in cancer progression. G1 Therapeutics became a subsidiary of Pharmacosmos A/S in September 2024. The company's flagship product, COSELA (trilaciclib), is an FDA-approved drug that protects bone marrow from chemotherapy damage. It is administered intravenously before chemotherapy to enhance patient safety. G1 Therapeutics also has a pipeline that includes lerociclib, a CDK4/6 inhibitor, and other investigational compounds aimed at cancer treatment. The company collaborates with organizations like GeneCentric Therapeutics and AstraZeneca to advance its research and clinical trials.

São Paulo, , Brazil

+1 919-213-9835

Founded: 2008


Journalist Hunt

Email us

contact@journalisthunt.com
Terms and ConditionsRefund PolicyPrivacy Policy

Copywright © 2025, Journalist Hunt. All right reserved